Lattice Biologics Ltd. (LBLTF)

OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Dec 3, 2025
0.00%
Market Cap 128.00
Revenue (ttm) 1.56M
Net Income (ttm) -951.65K
Shares Out 128.22M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 25,000
Average Volume 14,628
Open 0.0000
Previous Close 0.0000
Day's Range 0.0000 - 0.0000
52-Week Range 0.0000 - 0.0000
Beta 1.21
RSI 41.21
Earnings Date n/a

About Lattice Biologics

Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologics products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops acellular demineralized bone scaffold, a human cortical bone demineralized that are used in various applications in orthopedic, neurological, trauma, oral/maxillofacial, and reconstructive procedures; and acellular dermal matrix that provides a natural collagen tissue scaffold that promotes cellular ingrowth, tissue vascularization,... [Read more]

Industry Medical Devices
Sector Healthcare
Country Canada
Stock Exchange OTCMKTS
Ticker Symbol LBLTF
Full Company Profile

Financial Performance

In fiscal year 2020, Lattice Biologics's revenue was $2.46 million, an increase of 12.60% compared to the previous year's $2.19 million. Losses were -$1.48 million, 46.5% more than in 2019.

Financial Statements

News

There is no news available yet.